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The BOLERO trial (Bladder cancer: Open versus Lapar-
aroscopic or RObotic cystectomy) is a pilot study to
determine the feasibility of randomisation to open ver-
sus laparoscopic access cystectomy in patients with
bladder cancer. We describe the results of an embedded
qualitative sub-study which explored why patients
decline randomisation.
Methods
10 semi structured interviews were undertaken with
patients recruited from 3 sites in England. Data were
analysed for key themes.
Results
Most patients declined the trial because they had pre-
ferences for, and could choose, which surgical method
they would be given- in most cases the robotic option.
Patients described an intuitive ‘sense’ that favoured the
new technology and had carried out their own inqui-
ries, including internet research and talking with pre-
vious patients and with friends and family with medical
backgrounds. Medical histories and lifestyle considera-
tions also shaped these personalised choices. Of impor-
tance too, however, were the messages patients
perceived from their clinical encounters. Whilst some
patients felt their surgeon favoured the robotic option,
others interpreted ‘indirect’ cues such as the ‘estab-
lished’ reputation of the surgeon and surgical method
and comments made during pre-op assessments. Many
patients expressed a wish for greater direction from
their surgeon when making these decisions.
Conclusion
Patients like to exercise informed choice over the type
of surgery they receive. For trials where the ‘new tech-
nology’ is routinely available to patients, there will likely
be difficulties with recruitment. This questions the feasi-
bility of similar trials in the future.
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